Nanotechnology platforms; an innovative approach to brain tumor therapy
- PMID: 21801148
- DOI: 10.2174/157340611796799113
Nanotechnology platforms; an innovative approach to brain tumor therapy
Abstract
Nano Drug Delivery, as a treatment method against brain tumors, is a progressing area in the field of precise targeted drug administration methodology. The unresolved problems related to chemotherapy, other invasive therapeutic procedures and various obstructions offered by biological barriers are circumvented by nanodrug delivery. Recent dramatic developments in nanotechnology have created a lot of nano-devices which could be used against cancer. Infiltration, modulation of the Blood Brain Barrier, camouflaged from immune defense mechanism and the specific targeting of cancer affected cells are a few of the attractive features of nanodevices. We present here a review of newly evolved nanoplatforms in brain tumor therapy in which careful attention has been paid into various form nanoparticles, useful targeting ligands, altered chemotherapy agents and existing tumor therapy methods using nanotechnology.
Similar articles
-
Brain cancer diagnosis and therapy with nanoplatforms.Adv Drug Deliv Rev. 2006 Dec 1;58(14):1556-77. doi: 10.1016/j.addr.2006.09.012. Epub 2006 Sep 28. Adv Drug Deliv Rev. 2006. PMID: 17107738 Review.
-
Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.Curr Clin Pharmacol. 2018;13(2):110-119. doi: 10.2174/1574884713666180412150153. Curr Clin Pharmacol. 2018. PMID: 29651960 Review.
-
Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.Chem Soc Rev. 2019 Jun 4;48(11):2967-3014. doi: 10.1039/c8cs00805a. Chem Soc Rev. 2019. PMID: 31089607 Review.
-
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.Part Fibre Toxicol. 2010 Mar 3;7:3. doi: 10.1186/1743-8977-7-3. Part Fibre Toxicol. 2010. PMID: 20199661 Free PMC article. Review.
-
Perspectives on Dual Targeting Delivery Systems for Brain Tumors.J Neuroimmune Pharmacol. 2017 Mar;12(1):6-16. doi: 10.1007/s11481-016-9687-4. Epub 2016 Jun 8. J Neuroimmune Pharmacol. 2017. PMID: 27270720 Review.
Cited by
-
Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.Pharm Res. 2014 Mar;31(3):531-40. doi: 10.1007/s11095-013-1196-z. Epub 2013 Aug 31. Pharm Res. 2014. PMID: 23996470 Review.
-
Hyaluronan-Conjugated Carbon Quantum Dots for Bioimaging Use.ACS Appl Mater Interfaces. 2021 Jan 13;13(1):277-286. doi: 10.1021/acsami.0c20088. Epub 2020 Dec 23. ACS Appl Mater Interfaces. 2021. PMID: 33355448 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical